Skip to main content
logo
Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
6.89
+0.41 (6.33%)
At close: Sep 4, 2026, 4:00 PM EDT
6.71
-0.18 (-2.61%)
After-hours: Sep 4, 2026, 7:47 PM EDT

RGC Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
3,4148,42644300450-
Market Cap Growth
-46.27%19171.44%-85.42%-33.42%--
Enterprise Value
3,4128,41839284452-
Last Close Price
6.8917.040.090.610.91-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PB Ratio
2799.631733.675.3225.0126.36-
P/TBV Ratio
2799.631733.675.3224.9226.39-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.320.110.010.040.05-0.92
Net Debt / Equity Ratio
-1.62-0.90-0.96-0.93-0.92-0.91
Net Debt / EBITDA Ratio
0.281.181.781.862.10-2.67
Net Debt / FCF Ratio
0.471.331.972.232.59-4.72
Quick Ratio
1.427.3841.1319.0628.420.01
Current Ratio
1.427.3941.9219.1528.460.02
Return on Equity (ROE)
-177.66%-54.81%-43.18%-41.71%-116.10%-
Return on Assets (ROA)
-84.97%-33.20%-28.11%-25.59%-51.87%-202.15%
Return on Capital Employed (ROCE)
-529.30%-74.00%-57.50%-52.20%-43.70%34.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-0.21%-0.04%-9.84%-1.96%-1.65%-
FCF Yield
-0.12%-0.04%-9.16%-1.66%-1.34%-
Buyback Yield / Dilution
----1.62%-28.06%-
SEC Filings: 10-K · 10-Q